<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-azelaic-acid.xml</id>
  <title>Recalls Watch: Azelaic Acid</title>
  <link rel="self" href="https://recalls.watch/feed/substance-azelaic-acid.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-08-05T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99490/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Azelaic Acid Gel</title>
    <link href="https://recalls.watch/recall/fda/99490/"/>
    <updated>2026-08-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97619/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Azelaic Acid Gel</title>
    <link href="https://recalls.watch/recall/fda/97619/"/>
    <updated>2025-10-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Market complaints received for gritty texture (grainy)</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95022/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Glenmark</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95022"/>
    <updated>2024-08-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
</feed>
